Sort by
Medicine and Dentistry
Prostate Cancer
100%
Clear Cell Renal Cell Carcinoma
86%
Malignant Neoplasm
63%
Vitamin D
56%
American Indian
52%
Ethnic Disparity
35%
Odds Ratio
34%
Health Disparity
32%
Cancer Screening
26%
Surgery
25%
Racial Disparity
25%
Body Mass Index
25%
Vitamin D Deficiency
24%
Hypovitaminosis D
24%
Neoplasm
24%
Pulmonary Hypertension
21%
Supplementation
21%
Disease
20%
Kidney Cancer
20%
Hazard Ratio
19%
Sickle-Cell Disease
19%
Meta-Analysis
18%
Partial Nephrectomy
17%
Isotopes of Calcium
15%
Cancer Registry
14%
Overall Survival
14%
Gene Locus
13%
Prostatectomy
13%
Personalized Medicine
13%
Socioeconomic Status
12%
Randomized Clinical Trial
11%
Mortality Rate
10%
Case-Control Study
10%
Heart Ventricle Arrhythmia
10%
MHealth
10%
Cardiomyopathy
10%
Laparoscopic Surgery
10%
Hepatocellular Carcinoma
10%
Medicine
10%
Robot-Assisted Surgery
10%
Prostate Surgery
10%
Immune Response
10%
Organoid
10%
Interleukin 6
10%
Genetic Admixture
10%
Image Analysis
10%
Video Microscopy
10%
Sickle Cell
10%
Antioxidant
10%
Mendelian Randomization Analysis
10%
Keyphrases
Renal Cell Carcinoma
43%
Selenium
38%
Surgical Treatment
32%
Non-Hispanic White
28%
Native American
27%
Hispanic Americans
25%
Selenium Supplementation
25%
Type 2 Diabetes Mellitus (T2DM)
24%
Arizona
23%
Body Mass Index
22%
Clear Cell Renal Cell Carcinoma (ccRCC)
22%
Treatment Disparities
21%
Racial Disparities
21%
Overall Mortality
20%
Confidence Interval
17%
African American
15%
Kidney Cancer
14%
Early Onset
14%
Randomized Clinical Trial
14%
Cancer Patients
14%
White Patients
13%
American Indian or Alaska Native
12%
Effect Modification
12%
Antioxidant
12%
Colorectal Adenoma
12%
Experimental Medicine Approach
10%
Vitamin D Pathway
10%
Pathway Genes
10%
Health Framework
10%
Trifecta Outcomes
10%
Vitamin D Response
10%
Molecular Variation
10%
Cancer Disparities
10%
Racism
10%
Social Conditions
10%
Health Inequalities
10%
Mitochondrial Variation
10%
Prostate Enucleation
10%
Prostate Surgery
10%
Aymara
10%
Biological Pathways
10%
Prostate Organoids
10%
Hispanic Patients
10%
Health Disparities
10%
Social Determinants of Health (SDoH)
10%
Social Experience
10%
Adverse Pathology
10%
Neighborhood Characteristics
10%
Metachronous
10%
Serum Concentration
10%
Biochemistry, Genetics and Molecular Biology
Genetics
66%
Health Disparity
32%
Single-Nucleotide Polymorphism
24%
Vitamin D
23%
Genome-Wide Association Study
23%
Cancer Registry
21%
Hypovitaminosis D
20%
Genetic Divergence
20%
Mortality Rate
16%
Genetic Variation
15%
Gene Locus
13%
Single Nucleotide Polymorphism
12%
Blood Level
10%
Haptoglobin
10%
Lycopene
10%
Social Determinants of Health
10%
Immune Response
10%
Mitochondrial DNA
10%
Genetic Admixture
10%
Chromosome 5
10%
Glucocorticoid Receptor
10%
Skin Pigmentation
10%
Population
10%
Randomized Clinical Trial
10%
Insulin Resistance
10%
Insulin Sensitivity
10%
Cell Marker
10%
High Risk Population
10%
Medical Record
10%
DNA Methylation
10%
Polygenic Score
10%
Vitamin Blood Level
9%
Gene Expression
9%
Epigenetics
9%
Hemocyte
8%
Lutein
7%
Zeaxanthin
7%
Carcinogenesis
7%
APLP1
7%
Hydrophilic Interaction Chromatography
7%
Eicosanoid Receptor
6%
Gene Flow
6%
Patient Coding
6%
Case-Control Study
5%
Lifespan
5%
Tumor Progression
5%
Haplotype
5%
Catenin
5%
All Cause Mortality
5%
NLR Family Pyrin Domain containing 3
5%
